Ask AI

Library

Updates

Table of contents

Vasomotor rhinitis

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of vasomotor rhinitis are prepared by our editorial team based on guidelines from the American Academy of Allergy, Asthma & Immunology (AAAAI/ACAAI 2020).
1

Classification and risk stratification

Severity assessment: as per AAAAI/ACAAI 2020 guidelines, consider using a validated instrument (such as scoring system, scale, or questionnaire) to help determine the severity of rhinitis and to monitor the degree of disease control.
C
Create free account

Diagnostic investigations

Clinical examination
As per AAAAI/ACAAI 2020 guidelines:
Elicit a complete detailed history and perform physical examination in patients presenting with symptoms of rhinitis.
B
Review all current medications in patients presenting with symptoms of rhinitis to assess whether drug-induced rhinitis may be present.
A
Create free account

Medical management

Intranasal antihistamines
As per AAAAI/ACAAI 2020 guidelines:
Offer intranasal antihistamines as first-line monotherapy in patients with non-allergic rhinitis.
A
Consider offering intranasal antihistamines as first-line therapy in patients with non-allergic rhinitis.
C
Create free account

More topics in this section

  • Intranasal corticosteroids

  • Intranasal anticholinergics

  • Intranasal decongestants

  • Oral leukotriene receptor antagonists

  • Oral decongestants